SMILE Eye Surgery Success Rate: What the Numbers Mean and What They Do Not Guarantee

When patients ask me about the success rate of Small Incision Lenticule Extraction (SMILE), my first response is usually simple: success of what?
That is not an evasive answer, but an honest place to begin. Most people asking about SMILE success rate or SMILE laser eye surgery are not actually looking for a number in isolation. They are asking something more personal: Will this work for me? What are the chances I become the unlucky exception? Can I trust the surgeon in front of me? And if the result is not perfect, will I be abandoned?
As an ophthalmologist and refractive surgeon, my goal in this article is to answer that question properly: not by throwing out a percentage without context, but by explaining what the numbers actually measure, what they leave out, and how to think about your own odds more intelligently. SMILE is an FDA-approved laser vision correction procedure, but any quoted success rate still has to be interpreted carefully.
Table of Contents
Why SMILE Success Can Mean Three Different Things
In refractive surgery, success is not one thing.
The first definition is acuity-based success. This is the most familiar one to patients because it shows up in eye-chart numbers like 20/20 or 20/40. It answers the question: how well can you see without glasses or contact lenses after surgery?
The second definition is predictability-based success. This is about how closely the final prescription lands to the intended target, often reported as being within +/- 0.50 D or +/- 1.00 D of goal. It answers the question: how precisely did the treatment hit the planned correction for a given set of refractive errors?
The third definition is useful-vision success. This is the part patients usually care about most, even if they do not phrase it that way. Can you function well in daily life? Does the vision work for driving, reading signs, being on screens, cooking dinner, seeing your children across a room, and doing what you wanted surgery for in the first place? For many people, this is really a question of better vision and not having to wear glasses for most of the day.

These definitions overlap, but they are not interchangeable. A patient can hit a chart target and still feel disappointed. Another can land slightly off the tightest refractive target and still feel thrilled because their day-to-day vision works beautifully.
That is why a headline number without a label is not enough.
How to Interpret the Main SMILE Success Rate Metrics
When you see a percentage attached to SMILE success, it is usually measuring one of a few standard endpoints.
20/20 or better means the patient can read at 20 feet what a person with average normal distance vision can read at 20 feet. That is the benchmark most people instinctively care about.
20/40 or better is a broader functional benchmark. It means the patient has to be at 20 feet to see what a person with average normal distance vision could see at 40 feet, and this is also the legal minimum visual acuity required to drive without glasses in many settings.
Within +/- 0.50 D of target and within +/- 1.00 D of target are predictability measures. These are not chart-vision endpoints. They are ways of describing how close the final refractive result came to the planned correction. The tighter the range, the stricter the metric.
Safety is measured in a different way. These usually focus on whether the eye lost lines of best-corrected vision after surgery. In plain language, they ask whether the procedure preserved the best vision the eye was capable of with correction.
Another useful concept here is best-corrected visual acuity, sometimes shortened to BCVA. Patients do not need the acronym, but they do need the idea: the goal of refractive surgery is often to give you, without glasses or contact lenses, what glasses or contact lenses could give you before surgery. That is a more useful way to think about success than assuming the goal is some superhuman level of vision.
If a clinic quotes a high success rate without saying which of these endpoints it is using, the number is not very meaningful.
What the Research Generally Shows About SMILE Success Rates
The broad published picture for SMILE is strong, but the numbers only help if they are labeled.
In the U.S. FDA pivotal trial for myopia with or without astigmatism, about 89% of eyes achieved uncorrected distance vision of 20/20 or better at 12 months, and about 99% achieved 20/40 or better. In the same study, about 95% of eyes landed within +/- 0.50 D of the intended target and about 99% landed within +/- 1.00 D.
Safety outcomes were also strong. In that FDA dataset, no eyes lost 2 or more lines of corrected distance vision at stability. That matters because a refractive procedure is not just supposed to reduce dependence on glasses. It is also supposed to preserve the eye’s best potential vision.
Across meta-analyses, clinical studies, and longer-term follow-up, the overall pattern is similar: SMILE performs well on efficacy, predictability, safety, and stability, and is broadly comparable to other major corneal refractive procedures. Enhancement or retreatment rates are usually reported in the 2% to 4% range overall, though they can be lower in some modern series and higher in more complex prescriptions.
Patient satisfaction is usually high as well, often reported in the 90% to 98% range. But satisfaction is not the same as acuity, predictability, or safety. It is a useful layer, not a substitute for the objective endpoints.
The main thing to keep in mind is that a number like 95% or 99% only becomes useful once you know what it is measuring.
Why 20/20 Can Still Feel Like a Disappointment
One of the most important concepts in any success-rate discussion is what I think of as the unhappy 20/20 problem. A patient can measure 20/20 in the office and still tell me the vision feels off at home.
That does not mean the chart is useless. It means the chart is not the whole story. Vision can feel disappointing because of glare, ghosting, halos, contrast complaints, residual astigmatism, tear-film instability, dry eye, or simply because the patient’s expectations were more perfection-oriented than the metrics they were shown.
This is exactly why success rate cannot be reduced to one acuity percentage. A technically successful surgery may still feel imperfect to the patient living with it.
That does not mean SMILE performs poorly. It means clinical success and patient-perceived success are not identical concepts. This article is about that definition gap. If you want the fuller discussion of what settled vision actually feels like in daily life, I cover that in SMILE Eye Surgery Results: How Long Does SMILE Last?.
What Can Affect Your Personal Odds of a Strong Result
The way to think about whether you are at elevated risk is not to hunt for a more comforting aggregate number. It is to understand what actually changes the odds from one patient to another.
Prescription strength matters. A straightforward low-to-moderate myopic correction is not the same statistical situation as a very high myopic correction. Higher prescriptions can carry more nuance around predictability and regression.
Astigmatism matters too. Many patients with astigmatism do very well with SMILE, but the correction profile is not identical across all refractive shapes and magnitudes.
Corneal factors matter. The shape, thickness, regularity, and biomechanical profile of the cornea are part of what makes a case straightforward or more conditional. Thin corneas, suspicious topography, limited corneal tissue, or a concern about ectasia risk can all change the conversation.
Ocular surface health matters. Tear-film instability, untreated dry eye, and broader eye health concerns do not just affect comfort. They can affect measurements, visual quality, and the patient’s perception of the result.
And surgeon judgment matters. A good eye doctor or eye surgeon is not only evaluating whether a procedure can be performed. They are evaluating whether it is the smartest choice for this specific eye, this specific prescription, and this specific patient, and whether the patient is truly a good candidate for the SMILE procedure.
That is the more useful way to think about outlier fear. The reassuring answer is not usually a better population statistic. It is a more specific explanation of why your own anatomy and case profile do or do not place you in a higher-risk category.
How SMILE Compares at Very Tight Accuracy Endpoints
This is one place where transparency matters more than defensiveness. Some literature suggests that LASIK eye surgery may perform slightly better than SMILE on certain very tight predictability endpoints, particularly within +/- 0.50 D of target.
That is a real nuance and should not be hidden. But it also should not be exaggerated.
First, this is not the same as saying LASIK is broadly superior. Many studies still show no meaningful difference in broader visual-acuity success, within +/- 1.00 D, or safety outcomes.
Second, the nuance depends partly on what type of LASIK platform is being discussed and what kind of prescription is being treated. The difference is more relevant in some lower-prescription comparisons than in higher ones, where the picture can look more even.
So the right interpretation is not “LASIK wins.” It is: if you are comparing procedures at the strictest possible accuracy endpoint, some literature slightly favors LASIK in specific contexts.
Enhancement Rates: What If the First Result Is Not Quite Right?
This is another place where readers often hear the wrong emotional message. An enhancement rate is not the same thing as a failure rate.
If a patient needs a touch-up, that usually means the first result landed close, but not quite where the surgeon and patient wanted it to land. This means a refinement step is needed.
The most helpful thing to understand is that touch-ups are usually not rushed. A thoughtful surgeon does not jump into a second procedure just because the result is not perfect at one visit. The prescription is usually allowed to stabilize first. Follow-up matters. Re-measurement matters. Timing matters.
That process should actually reassure you. It means a possible enhancement is being approached deliberately, not reactively.
For patients, the practical takeaway is simple: a refinement option exists in the refractive-surgery ecosystem, and its existence does not mean the original surgery was a mistake. Depending on the case, that refinement may involve PRK or another follow-up strategy.
Why Online Stories Can Distort Your Sense of Risk
If you spend enough time on support forums, regret communities, Reddit threads, or comment sections, SMILE can start to look far riskier than the published outcomes suggest.
Online posts are often a skewed sample rather than a balanced picture of typical outcomes.
Patients who had a smooth, uneventful course are often busy living their life. Patients who are frightened, frustrated, or still looking for answers stay visible much longer. That makes the difficult outcome feel more common than it actually is.
This is especially important when gauging the success of a procedure like SMILE online, because readers are trying to reconcile two very different kinds of information: formal outcomes data and highly vivid personal anecdotes. Both matter. But they do not measure the same thing. The best way to use online posts is to let them show you what kinds of concerns can arise, not to let them entirely replace the statistical frame.
What to Ask a Surgeon About Success in Your Case
To understand what success is likely to look like in your case, ask:
- Which procedure is best for me, and why?
- Do you offer all the major refractive options, or only one or two?
- How do you define a successful outcome in a case like mine?
- What happens if my result is close, but not exactly on target?
- What do you do if I have side effects or quality-of-vision complaints?
Those questions are more useful because they turn the conversation from generic population statistics into surgeon judgment, patient selection, follow-through, and the difference between a population percentage and what patients experience in real life.
Success-rate questions are often really trust questions in disguise. The right consultation should answer both.
What to Remember About SMILE Success Rates
The best way to think about SMILE success rates is as labeled pieces of evidence, not as guarantees.
Success depends on what is being measured. A 20/20 rate, a predictability rate, a safety metric, and a satisfaction percentage are not interchangeable. Personal odds matter more than a headline stat. And the possibility of needing a refinement does not mean the original surgery failed.
The goal is not just chart vision. It is useful vision that holds up in real life. If you want the fuller discussion of what that feels like once healing has settled, SMILE Eye Surgery Results covers that side in more detail, and SMILE Recovery Timeline covers the question of recovery time.
Frequently Asked Questions About SMILE Success Rate
What is the success rate of SMILE eye surgery?
It depends on what outcome you are measuring. In the FDA pivotal trial, about 89% of eyes achieved 20/20 or better and about 99% achieved 20/40 or better at 12 months. If someone quotes a success rate without defining the endpoint, the number is incomplete.
How many SMILE patients achieve 20/20?
In major published data, the answer is often around the high 80% to low 90% range depending on the study population, prescription range, and follow-up period. That number should not be treated as a promise for every individual eye.
What percentage of SMILE patients need a touch-up?
Enhancement or retreatment rates are commonly reported in the 2% to 4% range overall, though the exact number varies by study and case mix. A touch-up is usually better understood as a refinement, not as a failed surgery, and refinements are a normal part of the refractive surgery process in some cases.
Can SMILE fail?
It can fall short of the ideal target, and some patients can be dissatisfied even with technically successful surgery or describe lingering vision problems despite strong chart outcomes. That is why the better question is not simply whether failure is possible, but what kind of outcome is being measured, what your personal risk factors are, what the potential risks are, and how your surgeon handles results that are not quite on target.
How does SMILE success rate compare to LASIK?
Broadly, SMILE and LASIK are both strong procedures with comparable overall efficacy and safety in many studies. Some literature suggests LASIK may do slightly better on very tight predictability endpoints such as within +/- 0.50 D, but that nuance is narrower than many readers assume and does not settle the larger procedure-choice question by itself.
What does a SMILE success-rate percentage actually measure?
Usually one specific endpoint: unaided chart vision, refractive predictability, safety, stability, or satisfaction. The most important habit is to ask: success by what measure?
Does SMILE affect future cataract surgery?
Not in the sense of preventing it. If you eventually need cataract surgery later in life, your surgeon simply needs to account for the fact that you previously had a laser-assisted corneal vision correction as part of your broader eye care history.
Do thin corneas or ectasia risk change the success conversation?
Yes. Thin corneas, limited corneal tissue, suspicious topography, or ectasia risk can change whether SMILE is the right option at all. In those cases, the real success question is not how high the percentage looks on paper, but whether the procedure is appropriate for your anatomy.
Can dryness, halos, or eye drops affect how success feels?
Yes. Dryness, halos, and the way patients use eye drops during healing can all influence how the results of a technically successful SMILE surgical procedure feel in real life. That is one reason chart outcomes and patient-perceived outcomes do not always line up perfectly.
If I am not a good candidate for SMILE, what else might be considered?
That depends on the reason. Some patients may be better served by ICL, PRK, or LASIK procedure, especially if the main concern is corneal anatomy, refractive range, or overall risk of complications rather than the headline percentage alone.